Sangamo Therapeutics Announces Presentations At 2018 Annual Meeting Of The American Society Of Gene & Cell Therapy

MAY 01, 2018 RICHMOND, Calif., May 1, 2018 /PRNewswire/ — Sangamo Therapeutics, Inc. (NASDAQ: SGMO) today announced that data from the Company’s technology and preclinical research programs will be presented at the 21stĀ Annual Meeting of the American Society of Gene